Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Celera Corp.

Division of Quest Diagnostics Inc.

Latest From Celera Corp.

People Briefs

Epigenomics, RainDance, and Brightree name new leadership, and more personnel news from around the industry.

Medical Device Regulation

Genentech Seeks Partners For Biomarker-Driven Drug Development Beyond Oncology

Roche subsidiary hopes recent deals with 23andMe and Human Longevity for whole genome sequencing will help identify targets and biomarkers for Parkinson's disease and other non-cancer conditions. Firm also is taking a personalized medicine approach to development of treatments for pain, macular degeneration and asthma.

BioPharmaceutical Clinical Trials

AbbVie Becomes An Overnight Oncology Force With Pharmacyclics

The company outbid two rivals to win Pharmacyclics and its fast-growing cancer drug Imbruvica in an expensive acquisition that will cost AbbVie about $21 billion. But the fact that Pharmacyclics shares sales and profits on Imbruvica with J&J may leave some investors questioning the high premium.

BioPharmaceutical Clinical Trials

Craig Venter Wants To Extend Your Life (And Own Your Data)

The onetime Celera CEO says his new attempt to centralize biological information into a massive database could lead to breakthroughs that extend the human life span. Behind that bold goal is a more mundane data-licensing strategy that, although not splashy, could still improve medicine.

BioPharmaceutical Personalized Medicine
See All

Company Information